HomeSWTX • NASDAQ
add
SpringWorks Therapeutics Inc
Previous close
$49.55
Day range
$46.63 - $49.26
Year range
$28.21 - $61.70
Market cap
3.60B USD
Avg Volume
3.10M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2024info | Y/Y change |
---|---|---|
Revenue | 61.55M | 1,029.96% |
Operating expense | 137.34M | 32.71% |
Net income | -77.30M | 18.05% |
Net profit margin | -125.59 | 92.75% |
Earnings per share | -1.04 | 28.28% |
EBITDA | -80.32M | 17.97% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 307.98M | -35.73% |
Total assets | 587.28M | -19.08% |
Total liabilities | 106.17M | 6.63% |
Total equity | 481.10M | — |
Shares outstanding | 74.92M | — |
Price to book | 7.66 | — |
Return on assets | -34.00% | — |
Return on capital | -39.54% | — |
Cash Flow
Net change in cash
(USD) | Dec 2024info | Y/Y change |
---|---|---|
Net income | -77.30M | 18.05% |
Cash from operations | -29.50M | 52.95% |
Cash from investing | 14.14M | 108.88% |
Cash from financing | 653.00K | -99.78% |
Net change in cash | -14.70M | -119.05% |
Free cash flow | -14.52M | 16.52% |
About
Founded
2017
Headquarters
Website
Employees
368